Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

recurrent Metastatic Squamous Neck Cancer With Occult Primary

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Treatment of Recurrent Metastatic Squamous Neck Cancer With Occult Primary

Broader topic: Metastatic Squamous Neck Cancer With Occult Primary

Source population
Not part of this definition
Disease extent
recurrent
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
    1. class
      prior therapy
      status
      stated
    derivation status
    source-attested
    derivation note
    Scoped from an NCI treatment-summary heading. NCI PDQ is an evidence summary, not a practice guideline, and only the dimensions the heading states are part of this definition.
    source wording
    Treatment of Recurrent Metastatic Squamous Neck Cancer With Occult Primary

    Study evidence for this setting

    9 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

    NCT00095628 · Registry condition search · Scope: unclear

    SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00387335 · Registry condition search · Scope: unclear

    Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

    4 outcome links · 2 safety-group records · 0 quality-of-life measures

    →

    NCT00507767 · Registry condition search · Scope: unclear

    Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

    1 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00513435 · Registry condition search · Scope: unclear

    Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

    2 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT00939627 · Registry condition search · Scope: unclear

    Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

    6 outcome links · 2 safety-group records · 1 quality-of-life measures

    →

    NCT01044433 · Registry condition search · Scope: unclear

    Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck

    5 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT01806675 · Registry condition search · Scope: unclear

    18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

    5 outcome links · 3 safety-group records · 1 quality-of-life measures

    →

    NCT01816984 · Registry condition search · Scope: unclear

    PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

    6 outcome links · 1 safety-group records · 0 quality-of-life measures

    →

    NCT02644122 · Registry condition search · Scope: unclear

    SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes

    5 outcome links · 1 safety-group records · 1 quality-of-life measures

    →
    Source relationships and population-mapping limitations
    bindings
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice